/
/
/

Viyash Scientific Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013
₹946 Cr₹920 Cr₹858 Cr₹424 Cr₹792 Cr₹772 Cr₹774 Cr₹369 Cr₹390 Cr₹361 Cr₹329 Cr₹346 Cr₹333 Cr₹367 Cr₹375 Cr₹338 Cr₹341 Cr₹384 Cr₹358 Cr₹351 Cr₹321 Cr₹362 Cr₹358 Cr₹349 Cr₹295 Cr₹301 Cr₹316 Cr₹284 Cr₹278 Cr₹282 Cr₹271 Cr₹252 Cr₹235 Cr₹233 Cr₹225 Cr₹198 Cr₹194 Cr₹200 Cr₹209 Cr₹229 Cr₹169 Cr₹157 Cr₹153 Cr₹156 Cr₹146 Cr₹133 Cr₹112 Cr₹108 Cr₹113 Cr₹107 Cr₹115 Cr₹115 Cr₹118 Cr
₹8 Cr₹16 Cr₹14 Cr₹2 Cr₹7 Cr₹10 Cr₹7 Cr₹5 Cr₹3 Cr₹4 Cr₹5 Cr₹2 Cr₹79 L₹2 Cr₹3 Cr₹91 L₹88 L₹4 Cr₹4 Cr₹74 L₹3 Cr₹1 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹98 L₹6 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹7 Cr₹4 Cr₹8 L₹5 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹10 Cr₹2 Cr₹90 L₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹79 L
₹955 Cr₹936 Cr₹872 Cr₹426 Cr₹798 Cr₹783 Cr₹781 Cr₹373 Cr₹393 Cr₹365 Cr₹334 Cr₹348 Cr₹334 Cr₹368 Cr₹378 Cr₹339 Cr₹342 Cr₹387 Cr₹362 Cr₹351 Cr₹323 Cr₹363 Cr₹361 Cr₹352 Cr₹297 Cr₹302 Cr₹317 Cr₹290 Cr₹279 Cr₹284 Cr₹273 Cr₹254 Cr₹237 Cr₹236 Cr₹228 Cr₹204 Cr₹198 Cr₹200 Cr₹214 Cr₹233 Cr₹171 Cr₹159 Cr₹155 Cr₹166 Cr₹149 Cr₹134 Cr₹117 Cr₹109 Cr₹115 Cr₹110 Cr₹117 Cr₹118 Cr₹119 Cr
₹830 Cr₹796 Cr₹741 Cr₹384 Cr₹728 Cr₹724 Cr₹733 Cr₹347 Cr₹365 Cr₹345 Cr₹323 Cr₹346 Cr₹356 Cr₹385 Cr₹379 Cr₹348 Cr₹353 Cr₹363 Cr₹335 Cr₹344 Cr₹313 Cr₹331 Cr₹303 Cr₹304 Cr₹263 Cr₹269 Cr₹279 Cr₹260 Cr₹252 Cr₹254 Cr₹246 Cr₹234 Cr₹222 Cr₹212 Cr₹218 Cr₹189 Cr₹189 Cr₹186 Cr₹215 Cr₹226 Cr₹170 Cr₹165 Cr₹155 Cr₹150 Cr₹137 Cr₹123 Cr₹120 Cr₹122 Cr₹114 Cr₹125 Cr₹117 Cr₹116 Cr₹118 Cr
₹187 Cr₹200 Cr₹190 Cr₹58 Cr₹126 Cr₹123 Cr₹106 Cr₹44 Cr₹45 Cr₹36 Cr₹27 Cr₹17 Cr-₹7 Cr-₹2 Cr₹13 Cr₹4 Cr₹3 Cr₹37 Cr₹40 Cr₹20 Cr₹23 Cr₹45 Cr₹69 Cr₹61 Cr₹47 Cr₹47 Cr₹51 Cr₹43 Cr₹40 Cr₹41 Cr₹38 Cr₹30 Cr₹24 Cr₹33 Cr₹22 Cr₹25 Cr₹19 Cr₹23 Cr₹13 Cr₹22 Cr₹14 Cr₹10 Cr₹12 Cr₹25 Cr₹21 Cr₹21 Cr₹6 Cr-₹5 Cr₹9 Cr-₹6 Cr₹7 Cr₹9 Cr₹7 Cr
₹13 Cr₹15 Cr₹17 Cr₹14 Cr₹20 Cr₹21 Cr₹21 Cr₹14 Cr₹16 Cr₹12 Cr₹13 Cr₹13 Cr₹10 Cr₹11 Cr₹10 Cr₹8 Cr₹7 Cr₹6 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹6 Cr₹7 Cr₹8 Cr₹9 Cr₹10 Cr₹8 Cr₹9 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹10 Cr₹10 Cr₹7 Cr₹6 Cr₹7 Cr₹8 Cr₹9 Cr₹8 Cr₹10 Cr₹8 Cr₹8 Cr₹11 Cr₹11 Cr₹12 Cr₹11 Cr₹11 Cr₹11 Cr₹10 Cr₹9 Cr₹9 Cr
₹112 Cr₹125 Cr₹73 Cr₹27 Cr₹48 Cr-₹37 Cr₹24 Cr₹8 Cr₹12 Cr₹3 Cr₹1 Cr-₹3 Cr-₹56 Cr-₹89 Cr-₹10 Cr-₹18 Cr-₹21 Cr₹18 Cr₹24 Cr₹4 Cr₹7 Cr₹29 Cr₹51 Cr₹32 Cr₹26 Cr₹24 Cr₹28 Cr₹23 Cr₹19 Cr₹22 Cr₹18 Cr₹12 Cr₹7 Cr₹13 Cr₹60 L₹8 Cr₹3 Cr₹7 Cr-₹9 Cr-₹2 Cr-₹7 Cr-₹16 Cr-₹8 Cr₹8 Cr₹74 L-₹16 Cr-₹14 Cr₹32 Cr-₹10 Cr-₹80 Cr-₹15 Cr-₹7 Cr-₹9 Cr
₹79 Cr₹66 Cr₹49 Cr₹20 Cr₹37 Cr-₹32 Cr₹42 Cr₹6 Cr₹9 Cr₹1 Cr₹11 Cr-₹7 Cr-₹35 Cr-₹92 Cr-₹10 Cr-₹4 Cr-₹15 Cr₹10 Cr₹19 Cr₹14 Cr₹3 Cr₹24 Cr₹40 Cr₹24 Cr₹19 Cr₹18 Cr₹24 Cr₹24 Cr₹15 Cr₹21 Cr₹16 Cr₹15 Cr₹4 Cr₹405 Cr-₹7 Cr₹31 Cr₹2 Cr₹11 Cr-₹11 Cr-₹4 Cr-₹12 Cr-₹15 Cr-₹8 Cr₹7 Cr-₹19 L-₹19 Cr-₹15 Cr₹33 Cr-₹11 Cr-₹80 Cr-₹15 Cr-₹7 Cr-₹9 Cr

Share Price Live Stats

Open (₹)260.80
Volume (₹)16.14 L
High (₹)265.70
Upper Circuit312.50
Low (₹)260.75
Lower Circuit208.40
Prev Close260.45
52W High (₹)298.00
Price265.20
52W Low (₹)175.26

Share Market Cap & Key Ratios Overview

M.Cap (₹)11461.80 Cr
Div. Yield (%)0.00
PE Ratio66.97
Debt to Equity0.16
Price to Book2.96
Book Value61.92
EPS (TTM)3.89
Face Value2.00
ROE (%)9.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
VIYASHNSE
LTP
1W Low
1W High
Market cap (₹)
1899.7-20.3 (-1.06%)
1896.80
1984.80
4,56,833Cr
9137.5-101.5 (-1.10%)
9087
9467
2,45,426Cr
4838.5-211.5 (-4.19%)
4823
5066
1,87,320Cr
1129.4-61.6 (-5.17%)
1125.10
1187
1,13,217Cr
1380-43.5 (-3.06%)
1376
1426.10
1,12,212Cr
1845.1-93.4 (-4.82%)
1811.70
1949
1,01,155Cr
2109.4-62.1 (-2.86%)
2107.20
2192
97,626Cr
2332.7-50.2 (-2.11%)
2327.30
2419.20
96,859Cr
1157-21 (-1.78%)
1154.40
1179.90
96,406Cr
1653.6+8.3 (0.50%)
1622.60
1717
93,614Cr
265.2-2.2 (-0.82%)
256.30
270.95
11,462Cr

Key Highlights of Viyash Scientific Ltd’s P&L

In 2026-03-31, Viyash Scientific Ltd reported total revenue of ₹3463.86Cr, compared with ₹3042.66Cr in 2025-03-31, reflecting Viyash Scientific Ltd turnover.

Depreciation was ₹233.64Cr and finance costs were ₹69.21Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹349.02Cr in 2026-03-31 as compared to ₹13.18Cr in 2025-03-31.

Net Profit (PAT) was ₹177.28Cr in 2026-03-31 compared with ₹23.22Cr in 2025-03-31.

Earnings per share (EPS) were ₹4.06 in 2026-03-31, compared with ₹0.93 in 2025-03-31.